Barr Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has upheld the 2005 decision of the U.S. District Court for the Eastern District of New York, which rejected a challenge to the lawfulness of a 1997 patent litigation settlement between its wholly owned subsidiary, Barr Laboratories, Inc., and Bayer Corporation related to the antibiotic Cipro(R).
The details can be read here.
The whole judgement can be read here.
No comments:
Post a Comment